# Aerosolized Mesenchymal Stem Cell-Derived Exosomes for the Prevention and Treatment of Radiation-Induced Oral Mucositis

> **NCT07312656** · PHASE2 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Guangxi Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Oral Mucositis (Ulcerative) Due to Radiation

## Interventions

- **DRUG:** mesenchymal stem cell-derived exosomes

## Key facts

- **NCT ID:** NCT07312656
- **Lead sponsor:** First Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-06
- **Final completion:** 2028-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07312656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07312656, "Aerosolized Mesenchymal Stem Cell-Derived Exosomes for the Prevention and Treatment of Radiation-Induced Oral Mucositis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07312656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*